bostrycin has been researched along with Lung Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, WS; Guo, YB; Hou, JN; Lin, YC; She, ZG; Xie, CM; Yang, HL | 1 |
1 other study(ies) available for bostrycin and Lung Neoplasms
Article | Year |
---|---|
Bostrycin inhibits proliferation of human lung carcinoma A549 cells via downregulation of the PI3K/Akt pathway.
Topics: Adenocarcinoma; Anthraquinones; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor Proteins; Down-Regulation; Humans; Lung Neoplasms; MicroRNAs; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction | 2011 |